Table 3.
Resources currently consulted when questions arise about pharmacogenomics
| Resources | Total respondents (n) |
|---|---|
| Scientific literature | 58.0% (174) |
| Internet (Google searches, WebMD, etc) | 49.3% (148) |
| Professional society literature/guidelines/recommendations | 47.3% (142) |
| Peer discussion | 41.7% (125) |
| Laboratory directors/personnel | 25.0% (75)a |
| Drug labeling | 20.7% (62) |
| FDA website | 17.7% (53)b |
| Insurance company/payer | 11.3% (34) |
| Have not consulted resources | 14.3% (43) |
| Do currently available resources enable you to access the pharmacogenomic information you need or want to know? | |
| Yes | 43.0% (129) |
| No | 57.0% (171) |
Notes:
a
Primary care physicians were significantly more likely than cardiologists to have consulted a laboratory director/personnel (29.8% versus 11.9%, P<0.05);
b
primary care physicians and psychiatrists were significantly more likely than cardiologists to have consulted the US Food and Drug Administration (FDA) website (18.8% and 26.7%, respectively, versus 5.1%; P<0.05).